AKT1 and hepatocellular carcinoma: In summary, the aforementioned studies collectively demonstrate that sCLU plays a pivotal role in stimulating the PI3K/AKT/GSK-3β signaling pathway, a process that significantly contributes to the progression and exacerbation of malignant characteristics in HCC.